121 related articles for article (PubMed ID: 29238391)
1. Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.
Hong J; Novick D; Moneta MV; El-Shafei A; Dueñas H; Haro JM
Clin Pract Epidemiol Ment Health; 2017; 13():145-155. PubMed ID: 29238391
[TBL] [Abstract][Full Text] [Related]
2. Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Novick D; Montgomery W; Haro JM; Moneta MV; Zhu G; Yue L; Hong J; Dueñas H; Brugnoli R
Neuropsychiatr Dis Treat; 2016; 12():383-92. PubMed ID: 26966361
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.
Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
Patient Prefer Adherence; 2015; 9():1481-90. PubMed ID: 26527865
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
5. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
[TBL] [Abstract][Full Text] [Related]
7. The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trials.
Wise TN; Meyers AL; Desaiah D; Mallinckrodt CH; Robinson MJ; Kajdasz DK
Prim Care Companion J Clin Psychiatry; 2008; 10(4):270-5. PubMed ID: 18787676
[TBL] [Abstract][Full Text] [Related]
8. An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis.
Kuga A; Tsuji T; Hayashi S; Matsubara M; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
Neuropsychiatr Dis Treat; 2017; 13():2105-2114. PubMed ID: 28831259
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
10. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.
Novick D; Hong J; Montgomery W; Dueñas H; Gado M; Haro JM
Neuropsychiatr Dis Treat; 2015; 11():197-205. PubMed ID: 25653529
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
12. Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy.
Kuga A; Otsubo T; Tsuji T; Hayashi S; Imagawa H; Fujikoshi S; Escobar R
Neuropsychiatr Dis Treat; 2019; 15():809-817. PubMed ID: 31040680
[TBL] [Abstract][Full Text] [Related]
13. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
14. Impact of pretreatment with antidepressants on the efficacy of duloxetine in terms of mood symptoms and functioning: an analysis of 15 pooled major depressive disorder studies.
Barros BR; Schacht A; Happich M; Televantou F; Berggren L; Walker DJ; Dueñas HJ
Prim Care Companion CNS Disord; 2014; 16(5):. PubMed ID: 25667808
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
16. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trials.
Ball SG; Desaiah D; Spann ME; Zhang Q; Russell JM; Robinson MJ; Demyttenaere K
Prim Care Companion CNS Disord; 2011; 13(6):. PubMed ID: 22454807
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
